HilleVax, Inc. (HLVX)
NASDAQ: HLVX · Real-Time Price · USD
1.900
+0.030 (1.60%)
Nov 4, 2024, 4:00 PM EST - Market closed
HilleVax Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 30.26 | 26.66 | 16.71 | 5.76 | 1.3 | 0.63 |
| Research & Development | 113.15 | 106.68 | 45.91 | 10.01 | - | - |
| Operating Expenses | 143.4 | 133.35 | 62.61 | 15.77 | 1.3 | 0.63 |
| Operating Income | -143.4 | -133.35 | -62.61 | -15.77 | -1.3 | -0.63 |
| Interest Expense | -2.91 | -2.39 | -3.41 | -2.84 | -0.03 | -0.01 |
| Interest & Investment Income | 8.78 | 9.71 | 3.88 | - | - | - |
| Other Non Operating Income (Expenses) | 2.22 | 2.47 | -43.69 | -46.14 | - | - |
| EBT Excluding Unusual Items | -135.31 | -123.57 | -105.84 | -64.75 | -1.32 | -0.64 |
| Other Unusual Items | - | - | -51.47 | - | -0.78 | -0.03 |
| Pretax Income | -156.27 | -123.57 | -159.81 | -102.41 | -2.1 | -0.67 |
| Net Income | -156.27 | -123.57 | -159.81 | -102.41 | -2.1 | -0.67 |
| Net Income to Common | -156.27 | -123.57 | -159.81 | -102.41 | -2.1 | -0.67 |
| Shares Outstanding (Basic) | 46 | 41 | 27 | 6 | 4 | 2 |
| Shares Outstanding (Diluted) | 46 | 41 | 27 | 6 | 4 | 2 |
| Shares Change (YoY) | 22.13% | 49.55% | 383.12% | 28.65% | 112.45% | - |
| EPS (Basic) | -3.39 | -3.04 | -5.89 | -18.22 | -0.48 | -0.33 |
| EPS (Diluted) | -3.39 | -3.04 | -5.89 | -18.22 | -0.48 | -0.33 |
| Free Cash Flow | -114.32 | -97.53 | -66 | -7.34 | -1.27 | -0.47 |
| Free Cash Flow Per Share | -2.48 | -2.40 | -2.43 | -1.31 | -0.29 | -0.23 |
| EBITDA | -141.71 | -132.47 | -62.61 | -15.77 | - | - |
| D&A For EBITDA | 1.7 | 0.88 | 0 | 0 | - | - |
| EBIT | -143.4 | -133.35 | -62.61 | -15.77 | -1.3 | -0.63 |
Source: S&P Capital IQ. Standard template.
Financial Sources.